Avanir Drug Nuedexta Wins FDA Approval for Uncontrolled Laughing, Crying
By Rob Waters – Oct 29, 2010
Avanir Pharmaceuticals Inc. won U.S. approval for a drug that curbs bouts of uncontrolled laughing or crying in patients with neurological disorders, regulators said. Shares more than doubled in extended trading.
The medicine, Nuedexta, is the first approved to treat patients with multiple sclerosis or Lou Gehrig’s disease who develop symptoms known as pseudobulbar affect that causes loss of emotional control, the Food and Drug Administration said in a statement. Avanir, which has no other products on the market, plans to begin selling the drug in the first three months of 2011, the Aliso Viejo, California, company said in a statement.
***********************************************************
“Providing You with ‘MS Views and News’, is what we do“
Keep Informed and up–to–date with information concerning
Multiple Sclerosis when registered at
the MS Views and News website.
****************************************************************
Disclaimer: ‘MS Views and News’ (MSVN), does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
. ****************************************************************
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews